4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001062993-23-020922
Director acquired 110,123 shares (grant or award)
- Director acquired 337,271 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Singer Michael Director | 2023-11-13 | Grant or award | +110,123 | 110,123 | D | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +197,663 | 197,663 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +29,212 | 29,212 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +3,670 | 3,670 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +49,555 | 49,555 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +49,555 | 49,555 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition | +7,616 | 7,616 | I | ||
| Derivatives | |||||||
| Singer Michael Director | 2023-11-13 | Grant or award · Series A Non-Voting Convertible Preferred Stock | +6,304.56 | 6,304.56 | D | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +11,316.26 | 11,316.26 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +1,672.39 | 1,672.39 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +210.15 | 210.15 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +2,837.05 | 2,837.05 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +2,837.05 | 2,837.05 | I | ||
| Singer Michael Director | 2023-11-13 | Other acquisition · Series A Non-Voting Convertible Preferred Stock | +436.07 | 436.07 | I | ||
Loading xslF345X05/form4.xml…